Nearly 10,000 mining machines seized at illegal mining farm in Russia's Ural region, causing electricity losses of almost 1.1 billion rubles
According to ChainCatcher, citing Bits.media, a large illegal cryptocurrency mining farm has been seized in Nizhny Tagil and the nearby Kushva region in Russia's Sverdlovsk Oblast. The mining farm was hidden within an abandoned industrial park and housed about 10 thousand mining machines. It was shut down during a joint operation by the Federal Security Service of Russia, local police, and a power company.
The local electricity company estimates that the mining farm's long-term illegal use of electricity caused losses of nearly 1 billion rubles (about $12.7 million). Investigators stated that its power consumption was enough to supply electricity to a small city. Law enforcement authorities have arrested three suspects, who are currently under house arrest, and have initiated a case on charges of "causing property damage through deception or abuse of trust." According to Russian law, those involved may face up to five years in prison.
Investigations revealed that the operators of the mining farm accessed the power grid through intermediaries and are suspected of tampering with meter data to conceal their actual electricity use. Law enforcement agencies reported that the farm’s real electricity consumption was about twice the approved amount. The local energy department initially launched an investigation due to frequent voltage fluctuations, power outages, and equipment failures in the abandoned factory area, eventually locating the farm. The local TV station also filmed a documentary called "Mining" to document the operation.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Forex Today: US flash Consumer Sentiment and Canadian jobs in the limelight
Malaysian Ringgit: Fiscal anchor case – MUFG
Nasdaq Drops Over 300 Points After OpenAI's Revenue Comes In $20 Billion Short
BUZZ-Revolution Medicines stock drops due to concerns over pancreatic cancer drug data
On October 8, Revolution Medicines (RVMD.O) shares fell 8.1% in afternoon trading to $185.91. RBC Capital Markets stated that the share price decline appeared to be driven by the latest U.S. Food and Drug Administration (FDA) review documents regarding the company's pancreatic cancer drug Rasonque, particularly the disclosure of objective response rate data for specific RAS mutation subgroups. RBC pointed out that overall survival, rather than objective response rate, is a more meaningful indicator of efficacy, and that the sell-off overlooked Rasonque's broad activity across a variety of RAS mutation subgroups. RBC stated: "While we acknowledge that today's share price decline takes place against the backdrop of overall weakness in the biotech sector, we still believe that the market's reaction to the FDA review documents is an overreaction, given that the drug was approved on the basis of highly clinically meaningful efficacy and has received positive feedback from physicians." Including intraday fluctuations, the stock has more than doubled year-to-date. (Note: For the convenience of non-English speakers, Reuters has automatically translated its reports into several other languages. Automated translations may be inaccurate or lack necessary context; Reuters does not guarantee the accuracy of these automated translations and provides them only for reader convenience. Reuters does not accept liability for any damage or loss arising from the use of automated translation features.)
